Figure 1: Distribution of LC50 values

Supplemental Table 1: LC50 values for classification of resistant and sensitive ALL for each chemotherapeutic agent. 4. Supplemental Table 2: Patient characteristics. 4. Supplemental Table 3: Permutation analysis and false discovery rate of probe sets selected by Wilcoxon rank sum test and t-test. 6. Supplemental Table 4: Number of significant ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.